# A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A

> **NCT01194180** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 48 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** BCG: 100 microlitres ~ 2-8 x 105 pfu
- **BIOLOGICAL:** MVA85A: 1 x 108 pfu BCG: 100 microlitres ~ 2-8 x 105 pfu

## Key facts

- **NCT ID:** NCT01194180
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01194180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01194180, "A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT01194180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*